IgA介导黏膜免疫及调节肠道菌群参与儿童哮喘发病的研究进展

Abstract
Figure/Table
References (43)
Related Citation (15)

Download: PDF (570 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Asthma is a common chronic respiratory disease in children, which seriously affects the physical and mental health and quality of life of children. The airways and intestines of children with asthma have varying degrees of damage to the mucosal epithelial cells, and immunoglobulin A (IgA) is the main antibody secreted by mucosal immunity, which can limit the colonization of the intestinal flora and maintain the balance of the intestinal flora and protect the epithelial cell layer Integrity, thereby preventing asthma and improving its prognosis. In addition, Chinese medicine has cloud “exteiror-interior relationship between lung and large intestine”, and “lung and bowel combined treatment” is a common method of clinical treatment of asthma, IgA may be a bridge between the lung and large intestine. This paper summarized the literature from the perspective of the effect of IgA in mucosal immunity on children’s asthma, in order to provide new ideas for the mechanism research of children’s asthma, provide new targets for clinical treatment, and provide scientific theoretical support for “exteiror-interior relationship between lung and large intestine”.

Key words： Iimmunoglobulin A Asthma Mucosal immunity Intestinal flora

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	HOU Shuting1
	2 LU Yuan3 ZHAO Xia1
	2

Cite this article:

HOU Shuting1,2 LU Yuan3 ZHAO Xia1,2. Research progress of IgA-mediated mucosal immunity and regulation of intestinal flora in the onset of childhood asthma[J]. 中国医药导报, 2021, 18(10): 31-34.

URL:

https://www.yiyaodaobao.com.cn/EN/ OR https://www.yiyaodaobao.com.cn/EN/Y2021/V18/I10/31

[1] Mims JW. Asthma：definitions and pathophysiology[J]. Int Forum Allergy Rhinol，2015，5 Suppl 1：S2-S6.
[2] Moossavi S，Miliku K，Sepehri S，et al. The Prebiotic and Probiotic Properties of Human Milk： Implications for Infant Immune Development and Pediatric Asthma[J]. Front Pediatr， 2018，6：197.
[3] Penders J，Stobberingh EE，van den Brandt PA，et al. The role of the intestinal microbiota in the development of atopic disorders [J]. Allergy，2007，62（11）：1223-1236.
[4] Kang YB，Cai Y，Zhang H. Gut microbiota and allergy/asthma： From pathogenesis to new therapeutic strategies[J]. Allergol Immunopathol（Madr），2017，45（3）：305-309.
[5] Melli LC，Do CM，Araujo-Filho HB，et al. Intestinal microbiota and allergic diseases： A systematic review [J]. Allergol Immunopathol（Madr），2016，44（2）：177-188.
[6] Xiao C，Puddicombe SM，Field S，et al. Defective epithelial barrier function in asthma [J]. J Allergy Clin Immunol，2011， 128（3）：549-556.
[7] Hammad H，Lambrecht BN. Barrier Epithelial Cells and the Control of Type 2 Immunity[J]. Immunity，2015，43（1）：29-40.
[8] 惠毅，闫曙光，郑旭锐，等.VIP-cAMP-PKA-AQP3信号通路与肺肠合治法治疗支气管哮喘的研究进展[J].中国中医基础医学杂志，2019，25（8）：1168-1170.
[9] Boonpiyathad T，S?觟zener ZC，Satitsuksanoa P，et al. Immunologic mechanisms in asthma[J]. Sem Immunol，2019，46：101333.
[10] 余涛，喻强强，丁明，等.基于Th17/Treg免疫失衡的益气温阳护卫法防治哮喘作用机制初探[J].时珍国医国药，2020，31（3）：654-656.
[11] 杨姮，段红梅，刘幼华，等.早期肠道菌群失调与儿童过敏性哮喘的关系[J].中华现代护理杂志，2020，26（20）：2698-2701.
[12] Loxham M，Davies DE. Phenotypic and genetic aspects of epithelial barrier function in asthmatic patients[J]. J Allergy Clin Immunol，2017，139（6）：1736-1751.
[13] Peterson LW，Artis D. Intestinal epithelial cells：regulators of barrier function and immune homeostasis[J]. Nat Rev Immunol，2014，14（3）：141-153.
[14] Zhu TH，Zhu TR，Tran KA，et al. Epithelial barrier dysfunctions in atopic dermatitis： a skin-gut-lung model linking microbiome alteration and immune dysregulation[J]. Br J Dermatol， 2018，179（3）：570-581.
[15] Jang S，Morris S，Lukacs NW. TSLP promotes induction of Th2 differentiation but is not necessary during established allergen-induced pulmonary disease[J]. PLoS One，2013，8（2）：e56433.
[16] Wang Q，Du J，Zhu J，et al. Thymic stromal lymphopoietin signaling in CD4（+） T cells is required for TH2 memory [J]. J Allergy Clin Immunol，2015，135（3）：781-791.
[17] Lin SC，Cheng FY，Liu JJ，et al. Expression and Regulation of Thymic Stromal Lymphopoietin and Thymic Stromal Lymphopoietin Receptor Heterocomplex in the Innate-Adaptive Immunity of Pediatric Asthma[J]. Int J Mol Sci，2018，19（4）：1231.
[18] Lei L，Zhang Y，Yao W，et al. Thymic stromal lymphopoietin interferes with airway tolerance by suppressing the generation of antigen-specific regulatory T cells [J]. J Immunol，2011，186（4）：2254-2261.
[19] Ying S，O’Connor B，Ratoff J，et al. Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity[J]. J Immunol，2005，174（12）：8183-8190.
[20] Tanaka J，Watanabe N，Kido M，et al. Human TSLP and TLR3 ligands promote differentiation of Th17 cells with a central memory phenotype under Th2-polarizing conditions [J]. Clin Exp Allergy，2009，39（1）：89-100.
[21] Dzidic M，Abrahamsson TR，Artacho A，et al. Aberrant IgA responses to the gut microbiota during infancy precede asthma and allergy development[J]. J Allergy Clin Immunol， 2017，139（3）：1017-1025.
[22] Lee MS，Kim YJ. Signaling pathways downstream of pattern-recognition receptors and their cross talk[J]. Annu Rev Biochem，2007，76：447-480.
[23] Cortes A，Munoz-Antoli C，Esteban JG，et al. Th2 and Th1 Responses： Clear and Hidden Sides of Immunity Against Intestinal Helminths [J]. Trends Parasitol，2017，33（9）：678-693.
[24] Marsland BJ，Trompette A，Gollwitzer ES. The Gut-Lung Axis in Respiratory Disease[J]. Ann Am Thorac Soc，2015，12 Suppl 2：S150-S156.
[25] Dumas A，Bernard L，Poquet Y，et al. The role of the lung microbiota and the gut-lung axis in respiratory infectious diseases [J]. Cell Microbiol，2018，20（12）：e12966.
[26] Mazanec MB，Nedrud JG，Kaetzel CS，et al. A three-tiered view of the role of IgA in mucosal defense [J]. Immunology today，1993，14（9）：430-435.
[27] Zuercher AW，Jiang HQ，Thurnheer MC，et al. Distinct mechanisms for cross-protection of the upper versus lower respiratory tract through intestinal priming[J]. J Immunol，2002，169（7）：3920-3925.
[28] Tulic MK，Piche T，Verhasselt V. Lung-gut cross-talk： evidence， mechanisms and implications for the mucosal inflammatory diseases [J]. Clin Exp Allergy，2016，46（4）：519-528.
[29] Perruzza L，Strati F，Gargari G，et al. Enrichment of intestinal Lactobacillus by enhanced secretory IgA coating alters glucose homeostasis in P2rx7-/- mice[J]. Sci Rep，2019，9（1）：9315.
[30] Wang W，Chen L，Zhou R，et al. Increased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease [J]. J Clin Microbiol，2014，52（2）：398-406.
[31] Catanzaro JR，Strauss JD，Bielecka A，et al. IgA-deficient humans exhibit gut microbiota dysbiosis despite secretion of compensatory IgM[J]. Sci Rep，2019，9（1）：13574.
[32] Dzidic M，Mira A，Artacho A，et al. Allergy development is associated with consumption of breastmilk with a reduced microbial richness in the first month of life[J]. Pediatr Allergy Immunol，2020，31（3）：250-257.
[33] Yazdani R，Azizi G，Abolhassani H，et al. Selective IgA Deficiency： Epidemiology，Pathogenesis，Clinical Phenotype， Diagnosis， Prognosis and Management[J]. Scand J Immunol，2017，85（1）：3-12.
[34] 李风森，徐丹，杜丽娟.黏膜免疫在支气管哮喘及变应性鼻炎发病中的作用[J].第二军医大学学报，2011，32（2）：182-186.
[35] 陆婉秋.儿童支气管哮喘与唾液中SIgA相关性初步研究[J].细胞与分子免疫学杂志，2009，25（8）：708-709.
[36] 李风森，徐丹，李明霞.哮喘与变应性鼻炎“肺鼻同治”的免疫学机理研究[J].北京中医药大学学报，2011，34（7）：500-504.
[37] 张艳丽，李风森，王璇.支气管哮喘患者血液、体液中黏膜免疫介质变化特点研究[J].临床肺科杂志，2011，16（5）：734-735.
[38] 苏军.不同证型哮喘患者体液及外周血中相关免疫指标的变化[D].乌鲁木齐：新疆医科大学，2012.
[39] 祖先鹏，林璋，谢海胜，等.中药有效成分与肠道菌群相互作用的研究进展[J].中国中药杂志，2016，41（10）：1766-1772.
[40] Dong Y，Yan H，Zhao X，et al. Gu-Ben-Fang-Xiao Decoction Ameliorated Murine Asthma in Remission Stage by Modulating Microbiota-Acetate-Tregs Axis[J]. Front Pharmacol，2020，11：549.
[41] 金津.固本止咳方对慢阻肺模型小鼠PIgR、SIgA等免疫分子影响的研究[D].北京：北京中医药大学，2017.
[42] 刘颖.固本止咳中药对慢阻肺模型小鼠肺组织γδT细胞及其相关细胞因子影响的研究[D].北京：北京中医药大学，2015.
[43] 陆远，赵霞，高莉娟，等.固本防哮饮对哮喘缓解期小鼠肺组织IL-4及IL-12的影响[J].中华中医药杂志，2015， 30（11）：4091-4093.